Apple's 2020 in review: COVID-19 pivots, clinical research partnerships and consumer device updates
Share Like most companies, Apple's plans for 2020 were upended with the rise of COVID-19. After initial hits to its production line, on-and-off store closures and remote working arrangements, executives said during Apple's fiscal fourth-quarter 2020 call that the tech firm weathered the storm with all-time records for revenue, earnings and cash flow – and that's before taking a look at its skyrocketing stock ticker. "Apple products have been a window to the world for users as the pandemic continues, and our teams have met the needs of this moment with creativity, passion and the kind...
Source: mobihealthnews.com